Key statistics
On Friday, IRadimed Corp (IRMD:NMQ) closed at 56.47, -1.14% below its 52-week high of 57.12, set on Nov 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 56.23 |
---|---|
High | 56.73 |
Low | 55.40 |
Bid | 56.06 |
Offer | 56.83 |
Previous close | 55.82 |
Average volume | 42.27k |
---|---|
Shares outstanding | 12.67m |
Free float | 7.99m |
P/E (TTM) | 38.67 |
Market cap | 715.67m USD |
EPS (TTM) | 1.46 USD |
Annual div (ADY) | 0.600 USD |
---|---|
Annual div yield (ADY) | 1.06% |
Div ex-date | Aug 20 2024 |
Div pay-date | Aug 30 2024 |
Next div ex-date | Nov 15 2024 |
Next div pay-date | Nov 25 2024 |
Data delayed at least 15 minutes, as of Nov 08 2024 21:00 GMT.
More ▼
- IRADIMED CORPORATION Named to Fortune’s 100 Fastest Growing Companies List for 2024
- IRADIMED CORPORATION Announces Third Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 Third Quarter Financial Results Conference Call on October 31st
- IRADIMED CORPORATION to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
- IRADIMED CORPORATION To Participate in the Lake St. Annual Best Ideas Growth “Big 8” Investor Conference
- IRADIMED CORPORATION Announces Second Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
- IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
- IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
- IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd
More ▼